Nordic Life Sience NO 04
Published: November 13, 2020
Top stories
Financing – October 27, 2026
Norwegian medtech company Medistim reported record third-quarter revenue of NOK 210.0 million, up 25.9% from NOK 166.8 million a year earlier. Operating profit rose 55.7% to NOK 63.1 million, and the board decided on the company’s first quarterly dividend, NOK 2.50 per share.
In a new job – October 27, 2026
Swedish peptide purification company Nanologica has appointed board member Mark Quick as CEO as it shifts its commercial focus toward North America and Europe. The company also plans a rights issue of approximately SEK 110.5 million.
Science Award – October 27, 2026
Forska!Sverige has established a new entrepreneurship award in memory of inventor and entrepreneur Leif Lundblad. The first recipient is Ulf Landegren, Professor of Molecular Medicine at Uppsala University, who has built several successful life science companies while helping other researchers do the same.
Science Award – October 27, 2026
Karolinska Institutet researchers Tim Baker and Carl Otto Schell have received the Lancet–Elsevier Foundation Evidence to Impact Award for Essential Emergency and Critical Care (EECC), a set of 40 basic treatments for critically ill patients on regular hospital wards.
Related posts
This site uses cookies